Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Virtus Lifesci Biotech Products ETF (BBP)

Virtus Lifesci Biotech Products ETF (BBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Virtus ETF Advisors LLC
  • Assets Under Management 19,585,700
  • Shares Outstanding, K 350
  • 60-Month Beta 0.73
Trade BBP with:
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 0.072 on 12/20/17
  • Management Fee 0.79%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
50.43 +1.05%
on 04/19/24
57.16 -10.84%
on 03/21/24
-5.16 (-9.20%)
since 03/19/24
3-Month
50.43 +1.05%
on 04/19/24
63.25 -19.43%
on 02/27/24
-6.06 (-10.62%)
since 01/19/24
52-Week
45.00 +13.25%
on 10/27/23
63.25 -19.43%
on 02/27/24
-0.80 (-1.54%)
since 04/19/23

Most Recent Stories

More News
5 Least-Hurt Biotech ETFs of the Last Week

Rising rate worries have weighed on the biotech sector. However, these biotech ETFs still have lost the least in recent days.

REGN : 896.82 (+0.32%)
BMY : 48.93 (+1.30%)
AMGN : 268.93 (+2.35%)
GILD : 66.76 (+0.91%)
IBB : 124.72 (+0.06%)
LABD : 10.80 (+2.66%)
BBH : 152.36 (+0.24%)
FBT : 141.68 (+0.11%)
PBE : 59.85 (+0.39%)
BBP : 50.96 (+0.72%)
2 Sector ETFs Hovering Around a 52-Week High

We all know that Wall Street is shattered this year. Still, two sectors -- Biotech and Aerospace -- have recently hit a 52-week high.

VRTX : 394.28 (+0.20%)
ONCY : 1.0600 (+2.91%)
ITA : 128.00 (+0.42%)
PPA : 98.31 (+0.20%)
BBP : 50.96 (+0.72%)
FTXH : 25.86 (+0.33%)
5 Best Areas of Q3 of 2022 & Their Top ETFs

These ETF areas won in the third quarter of 2022.

BBC : 24.88 (-1.96%)
MLPA : 47.69 (+1.25%)
QCLN : 30.48 (-0.81%)
EWZS : 13.02 (+1.72%)
SMIN : 72.79 (+0.11%)
BBP : 50.96 (+0.72%)
URA : 28.83 (-0.17%)
MLPB : 23.44 (+1.46%)
Biotech & Crypto -- Best ETF Areas of Last Week

Biotech and cryptocurrency -- two ETF areas outperformed last week.

SBIO : 31.59 (-0.67%)
BBP : 50.96 (+0.72%)
ARKF : 26.68 (-1.73%)
DAPP : 8.99 (+1.93%)
CRPT : 11.18 (+4.58%)
MSGR : 13.91 (+0.73%)
FDIG : 24.45 (+1.45%)
Biotech Wins Last Week: 5 Best ETFs

The biotech corner of the broad healthcare sector outperformed last week on speculation over a takeover bid for Global Blood Therapeutics.

PFE : 26.00 (+2.40%)
GBT : 68.49 (+0.01%)
BBC : 24.88 (-1.96%)
XBI : 82.83 (-0.78%)
SBIO : 31.59 (-0.67%)
BBP : 50.96 (+0.72%)
The Zacks Analyst Blog Highlights BBC, CNCR XBI, BBP, and SBIO

BBC, CNCR, XBI, BBP, and SBIO are part of Zacks top Analyst Blog.

CNCR : 14.11 (-1.74%)
BBC : 24.88 (-1.96%)
XBI : 82.83 (-0.78%)
SBIO : 31.59 (-0.67%)
BBP : 50.96 (+0.72%)
5 ETFs Riding High on the Biotech Comeback

Biotech, the downtrodden segment of the market, has made a solid comeback on bargain hunting.

CNCR : 14.11 (-1.74%)
BBC : 24.88 (-1.96%)
XBI : 82.83 (-0.78%)
SBIO : 31.59 (-0.67%)
BBP : 50.96 (+0.72%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Fund Summary

The Virtus LifeSci Biotech Products ETF seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index, which tracks the performance of biotechnology companies with at least one drug therapy approved by the FDA.

See More

Key Turning Points

3rd Resistance Point 51.67
2nd Resistance Point 51.32
1st Resistance Point 51.14
Last Price 50.96
1st Support Level 50.61
2nd Support Level 50.25
3rd Support Level 50.08

See More

52-Week High 63.25
Fibonacci 61.8% 56.28
Fibonacci 50% 54.13
Fibonacci 38.2% 51.97
Last Price 50.96
52-Week Low 45.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar